Building global development strategies for cf therapeutics during a transitional cftr modulator era.

Mayer-Hamblett N, van Koningsbruggen-Rietschel S, Nichols DP, VanDevanter DR, Davies JC, Lee T, Durmowicz AG, Ratjen F, Konstan MW, Pearson K, Bell SC, Clancy JP, Taylor-Cousar JL, De Boeck K, Donaldson SH, Downey DG, Flume PA, Drevinek P, Goss CH, Fajac I, Magaret AS, Quon BS, Singleton SM, VanDalfsen JM, Retsch-Bogart GZ

Open source

DOI: 10.1016/j.jcf.2020.05.011
Published: 2020 Sep
Container: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jcf.2020.05.011,
  title = {Building global development strategies for cf therapeutics during a transitional cftr modulator era.},
  author = {Mayer-Hamblett N and van Koningsbruggen-Rietschel S and Nichols DP and VanDevanter DR and Davies JC and Lee T and Durmowicz AG and Ratjen F and Konstan MW and Pearson K and Bell SC and Clancy JP and Taylor-Cousar JL and De Boeck K and Donaldson SH and Downey DG and Flume PA and Drevinek P and Goss CH and Fajac I and Magaret AS and Quon BS and Singleton SM and VanDalfsen JM and Retsch-Bogart GZ},
  year = {2020},
  journal = {Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society},
  doi = {10.1016/j.jcf.2020.05.011},
  url = {https://doi.org/10.1016/j.jcf.2020.05.011}
}

RIS

TY  - JOUR
TI  - Building global development strategies for cf therapeutics during a transitional cftr modulator era.
AU  - Mayer-Hamblett N
AU  - van Koningsbruggen-Rietschel S
AU  - Nichols DP
AU  - VanDevanter DR
AU  - Davies JC
AU  - Lee T
AU  - Durmowicz AG
AU  - Ratjen F
AU  - Konstan MW
AU  - Pearson K
AU  - Bell SC
AU  - Clancy JP
AU  - Taylor-Cousar JL
AU  - De Boeck K
AU  - Donaldson SH
AU  - Downey DG
AU  - Flume PA
AU  - Drevinek P
AU  - Goss CH
AU  - Fajac I
AU  - Magaret AS
AU  - Quon BS
AU  - Singleton SM
AU  - VanDalfsen JM
AU  - Retsch-Bogart GZ
PY  - 2020
JO  - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
DO  - 10.1016/j.jcf.2020.05.011
UR  - https://doi.org/10.1016/j.jcf.2020.05.011
ER  -

APA

N, M., S, V. K., DP, N., DR, V., JC, D., T, L., AG, D., F, R., MW, K., K, P., SC, B., JP, C., JL, T., K, D. B., SH, D., DG, D., PA, F., P, D., CH, G., I, F., AS, M., BS, Q., SM, S., JM, V., & GZ, R. (2020). Building global development strategies for cf therapeutics during a transitional cftr modulator era.. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. https://doi.org/10.1016/j.jcf.2020.05.011

Source records

pubmed · retrieved 2026-09-26T08:48:55.867Z